Czech Republic
France
Germany
Norway
Netherlands
Spain
Turkey
United KingdomUpdates
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Accupro 5mg, 10mg, 20mg, 40mg film-coated tablets
Pfizer Limited are recalling all batches of Accupro 5mg, 10mg, 20mg, 40mg film-coated tablets as a precautionary measure.
MHRA drug alert link:
Pip code | Product description | Supplier | Batch Numbers |
258764 | ACCUPRO TAB 5MG X 28 | PFIZER LTD | FJ7218 EY5501 EA9306 |
258780 | ACCUPRO TAB 10MG X 28 | PFIZER LTD | FK8588 EP6753 |
258822 | ACCUPRO TAB 20MG X 28 | PFIZER LTD | FF8046 FF8045 EA9304 DK4190 |
2035467 | ACCUPRO TAB 40MG X 28 | PFIZER LTD | FK9758 EP1602 CW7390 |
Further Information
For medical information enquiries, please contact Pfizer Medical Information Department on 01304 616161.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE:
Alcura Rated “Good” in CQC Report
Alcura receive “Good” in its recent Care Quality Commission (CQC) report a high standard in a competitive market. “This accreditation will go a long way in demonstrating to our patients, future patients, the NHS and manufacturers, the high-level of patient care we deliver at Alcura. As a purpose led organisation, we are dedicated to patient care, so to receive this recognition for our safety is a fantastic reflection of our knowledge and expertise in homecare,” said Pip Reid, Head of Nursing, Alcura.
Alcura received the second highest possible score in its recent CQC report, following the recent unannounced inspection at Alcura House. CQC, the independent regulator of health and social care in England, completed an intense two-day inspection at the Alcura site in Northampton, in February, and recently published the report on its website.
Alcura was inspected as part of the Community Services pillar and its support to care in patient homes, where there is a big emphasis on safety.
The CQC Inspection Report is based on a combination of what the organisation finds when they undertake the inspection, the information from its ongoing monitoring of data about services and information handed by the provider, patients, the public and other organisation. The report covers five questions and areas within the services provided across: Safety, Effectiveness, Caring, Responsiveness and Leadership.
CQC findings conclude that: “We rated the service as good because [..] The service had enough staff to care for patients and keep them safe. Alcura House had a pool of regular bank staff and did not use agency staff. Patients therefore received consistent care from the same nurses. All nursing staff had training in key clinical skills which had been tested through competency assessments.”
Other findings include: “Staff provide good care and treatment [..] Staff treated patients with compassion and kindness [..] Staff understood how to protect patients from abuse [..] Staff assessed risks to patients, acted on them and kept good care records.”
At the time of this inspection, Alcura had 1,252 clinical interactions per month and was supporting 45,000 registered patients. Alcura is committed to maintaining the high standards of patient safety and to identify and implement steps required to reach the highest CQC score - outstanding.
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Sodium bicarbonate 1.26% Solution for infusion 500ml
Fresenius Kabi Limited are recalling the below batch of product as a precautionary measure due to the identification of particles in the solution for infusion, following routine batch analysis and subsequent batches manufactured on the same filling line. The company’s investigation indicates that he particles appear to originate from the interaction between the equipment and the packaging material during the filling process. The integrity of the packaging and sterility of the product are not compromised.
MHRA drug alert link:
Pip code | Product description | Supplier | Batch Number |
ALLIANCE DO NOT STOCK | SODIUM BICARBONATE 1.26% SOLUTION FOR INFUSION 500ML | FRESENIUS KABI LIMITED | 22BC01 |
Further Information
For more information, medical or supply enquiries, please contact 01928 533 758 FK.Complaints-UK@fresenius-Kabi.com or Customer.Services-UK@Fresenius-Kabi.com
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Paroxetine 40mg Film Coated X 30 Tablets
Crescent Pharma Limited are recalling the below batch of product as a precautionary measure due to out of specification results for dissolution during routine stability testing.
MHRA drug alert link:
Pip code | Product description | Supplier | Batch Numbers |
8150096 | PAROXETINE TAB 40MG X 30 | CRESCENT PHARMA LTD | 06309 |
Further Information
For more information, medical or supply enquiries, please contact 01256 772730
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE:
Early May 2022 Bank Holiday Opening Hours now available
To help keep our customers informed of changes to our service, we have published our Early May 2022 Bank Holiday opening hours.
Find out more information by clicking here.
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 Drug Caution In Use - Depo-Medrone with Lidocaine 40 mg/mL (1 mL and 2 mL vials – single vial preparations)
Pfizer Limited have informed the MHRA that an outdated version of the Patient Information Leaflet (PIL) has been included in the packaging of the above mentioned batches of Depo-Medrone with Lidocaine (Methylprednisolone acetate and Lidocaine hydrochloride) 40 mg/mL 1 mL and 2 mL vials (single vial presentations) to the UK market.
MHRA drug alert link:
Pip code | Product description | Supplier | Batch Numbers |
2343036 | DEPO MEDRONE LIDOCAIN 40MG/ML, 1ML | PFIZER LTD | EL4771 FK6842 |
294892 | DEPO MEDRONE LIDOCAIN 40MG/ML, 2ML | PFIZER LTD | EK3997 FK6089 FN9557 |
This is a caution in use only we are not accepting stock returns.
Further Information
If you have any questions, please contact Pfizer Medical Information Department on 01304 616161
SUB-TYPE:
Alliance Healthcare Celebrates Earth Day
Happy Earth Day!
Today, and every day across Alliance Healthcare we celebrate our wonderful planet and reflect on the impact we are making. We will continue to create a sustainable operation that will support UK patients for the years to come and that will protect the planet for future generations.
Everyone at Alliance Healthcare has been encouraged to make a personal sustainability pledge as we all continue to play a role in this commitment.
Check out the below video to see what some of our employees are doing to help reduce the impact on the environment.
SUB-TYPE:
Alliance Healthcare to enter into a reduced wholesale agreement with AGB Pharma
We are pleased to announce that, as of 25 April 2022, Alliance Healthcare UK will become one of the chosen wholesalers to supply AGB Pharma’s Adaflex to all pharmacies, hospitals and dispensing doctors in the UK, including Northern Ireland.
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Olopatadine USV 1mg/mL eye drops 5ml
USV UK Limited are recalling specific batches of products as a precautionary measure due to out of specification results for impurities during routine stability testing.
MHRA drug alert link:
Pip code | Product description | Livery | Batch Numbers |
8943771 | OLOPATADINE USV 1MG-ML EYE DROPS 5ML | USV UK LIMITED | 35000201 35000202 35000203 35000204 35000206 |
Further Information
For more information, medical or supply enquiries, please contact info@ennogen.com
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE:
Training Matters (TM) meets our award-winning team at our Coatbridge Service Centre!
Our service centre teams are the power behind our large operation here at Alliance Healthcare UK. The recent TM visit was a great chance for us to show what happens behind-the-scenes in a fast paced supply chain operation and the brilliant team behind it.
Our Coatbridge Service Centre was originally based in Livingston, however our team made the move to Coatbridge in 2017 to enable room for expansion.
Lee Jamieson, Service Centre Manager has been the driving force to the success of our operation in Coatbridge, and said: “We went from being – at the time – the worst in the network for damages, stock write-offs and missing parcels to being one of the best sites in the network, which is an absolute credit to the people down there on the floor.
“To turn what was the worst into one of the best is incredible and it’s been well executed to get there. No one person can do that all on their own – you’re only as good as your team.”
You can read the full article here 👉An award-winning team (tmmagazine.co.uk)
